IRIS
PIERONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.360
AS - Asia 3.003
EU - Europa 1.815
SA - Sud America 446
AF - Africa 179
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.282
SG - Singapore 1.016
CN - Cina 773
VN - Vietnam 518
IT - Italia 403
BR - Brasile 343
IE - Irlanda 299
SE - Svezia 232
HK - Hong Kong 229
DE - Germania 171
FI - Finlandia 152
TR - Turchia 114
ZA - Sudafrica 107
FR - Francia 104
NL - Olanda 97
GB - Regno Unito 67
RU - Federazione Russa 65
IN - India 62
AT - Austria 51
AR - Argentina 40
BD - Bangladesh 40
KR - Corea 40
CA - Canada 36
CI - Costa d'Avorio 28
IQ - Iraq 28
ES - Italia 27
ID - Indonesia 27
JP - Giappone 26
MX - Messico 26
BE - Belgio 25
PL - Polonia 25
PK - Pakistan 22
PH - Filippine 20
CZ - Repubblica Ceca 19
UA - Ucraina 15
SA - Arabia Saudita 14
VE - Venezuela 14
CO - Colombia 13
LT - Lituania 12
LU - Lussemburgo 12
EC - Ecuador 11
GH - Ghana 11
UZ - Uzbekistan 11
MA - Marocco 9
AE - Emirati Arabi Uniti 7
CL - Cile 7
EG - Egitto 7
TH - Thailandia 7
TW - Taiwan 7
BO - Bolivia 6
IL - Israele 6
MY - Malesia 6
PY - Paraguay 6
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
KZ - Kazakistan 5
TN - Tunisia 5
CH - Svizzera 4
DZ - Algeria 4
KG - Kirghizistan 4
LV - Lettonia 4
PA - Panama 4
PE - Perù 4
SN - Senegal 4
CR - Costa Rica 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
ME - Montenegro 1
ML - Mali 1
Totale 8.803
Salva come PNG Salva come JPEG
Città #
Singapore 556
Ashburn 471
Chandler 339
San Jose 328
Dublin 296
Dallas 259
Hong Kong 212
Santa Clara 206
Beijing 166
Ho Chi Minh City 158
Ann Arbor 146
Hanoi 118
Parma 117
Johannesburg 99
Boardman 97
Los Angeles 90
Izmir 73
Shanghai 73
Dearborn 72
Munich 63
Lauterbourg 62
Nanjing 62
New York 60
Hefei 59
Princeton 57
Helsinki 55
Columbus 46
Wilmington 43
Bremen 40
Council Bluffs 40
Vienna 37
Chicago 35
São Paulo 33
Moscow 31
Buffalo 30
Turku 30
Abidjan 28
The Dalles 28
Hillsboro 27
Bologna 25
Guangzhou 24
Seoul 23
Haiphong 22
Frankfurt am Main 21
Kocaeli 21
London 21
Warsaw 21
Da Nang 20
Atlanta 19
Jakarta 19
San Mateo 18
Seattle 18
Shenyang 18
Tokyo 18
Brooklyn 17
Brussels 17
Milan 17
Nanchang 17
Falls Church 16
Hebei 16
Houston 15
Changsha 14
Chennai 14
Brasília 13
Jinan 13
Orem 13
Brno 12
Jiaxing 12
Norwalk 12
Amsterdam 10
Baghdad 10
Curitiba 10
Kyiv 10
Montreal 10
Nuremberg 10
Toronto 10
Accra 9
Istanbul 9
Denver 8
Des Moines 8
Fremont 8
Luxembourg 8
Phoenix 8
Porto Alegre 8
Rio de Janeiro 8
Rome 8
Verona 8
Bengaluru 7
Cairo 7
Caracas 7
Florence 7
Manchester 7
Stockholm 7
Tashkent 7
Tianjin 7
Washington 7
Belo Horizonte 6
Can Tho 6
Dalmine 6
Hải Dương 6
Totale 5.515
Salva come PNG Salva come JPEG
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 264
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 219
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 201
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 198
Nuovi composti antimicrobici 193
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 190
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 190
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 183
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 179
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 178
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 176
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 174
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 171
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 166
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 165
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 164
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 163
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 160
Antituberculosis agents: Beyond medicinal chemistry rules 157
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 157
Towards the sustainable discovery and development of new antibiotics 155
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 147
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 144
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 143
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 143
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 142
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 142
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 142
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 141
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 141
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 138
Quorum sensing inhibitors (QSIs): a patent review (2019–2023) 133
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 132
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 130
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 130
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 130
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 125
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 122
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 121
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 121
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 120
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 119
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 118
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 118
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 117
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 112
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 111
Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes 108
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 96
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 94
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 93
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 92
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 91
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 88
Indoleamides are active against drug-resistant mycobacterium tuberculosis 84
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 84
Benzotriazole derivatives as alternate O-acetylserine sulfhydrylase substrates to impair cysteine biosynthesis in Gram-negative bacteria 83
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 82
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 76
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype 72
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 72
Spectinamides: A challenge, a proof, and a suggestion 72
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 72
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 72
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 72
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 70
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 70
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 68
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 61
Gaining insights into MmpL3: combining structural and computational approaches to unlock transport and inhibitor-binding mechanisms 18
Totale 8.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 0 21
2021/2022379 15 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/20251.751 64 90 144 95 151 221 109 69 155 163 195 295
2025/20264.065 414 357 554 359 563 225 448 157 470 291 154 73
Totale 8.975